Kim, Jae Hui
Kim, Chul Gu
Lee, Dong Won
Yoo, Su Jin
Lew, Young Ju
Cho, Han Joo
Kim, Joo Yeon
Lee, Seok Hyun
Kim, Jong Woo
Funding for this research was provided by:
Bayer Korea (17860)
Article History
Received: 27 May 2019
Revised: 21 August 2019
Accepted: 7 September 2019
First Online: 18 November 2019
Compliance with ethical standards
:
: Jae Hui Kim: advisory board of Bayer and Novartis. The following authors have no financial disclosure: Chul Gu Kim, Dong Won Lee, Su Jin Yoo, Young Ju Lew, Han Joo Cho, Joo Yeon Kim, Seok Hyun Lee, Jong Woo Kim.
: The study was approved by the institutional review board of Kim’s Eye Hospital (Seoul, South Korea). This study was conducted in accordance with the tenets of the Declaration of Helsinki.
: Informed consent was obtained for all the patients before study enrollment. Identifying information about participants is not presented in this study.